Allergy Therapeutics has adopted electronic communications. This means that shareholders will receive documents from the Company electronically unless they elect to receive hard copies.
All of the Group’s annual results and interim results will be published on this website. Please click here to view the financial reports.
Shareholders can request hard copies of certain Company publications by contacting the Company.
If you are a shareholder who has elected to receive hard copies of documents and you now wish to receive electronic communications, please contact our UK registrars, Capita Asset Services on 0871 664 0300. Calls cost 12p per minute plus network extras. If telephoning from overseas, please dial +44 371 664 0300. Shareholders may revoke an election to receive electronic communications at any time.